HUM-MOLGEN events: Predictive Toxicology

HUM-MOLGEN -> Events -> Meetings and Conferences

September 12, 2003

Cambridge Healthtech Institute, Boston Park Plaza Hotel, Boston, Massachusetts
November 19-20, 2003

With 50% of drug failures attributed to ADME-Tox issues, it is critical to accurately predict these qualities earlier in the investigation of a lead to assure appropriate attrition from the drug development process. Empirical assays have been the mainstay of evaluating ADME and toxicity, but they suffer from low throughput are difficult to automate. New techniques and technologies for predicting these qualities must become more accurate and are able to be validated against empirical findings. It will then be possible to drop compounds that are most likely to exhibit ADME or toxicity problems sooner, and provide ways for researchers to arrive at correct conclusions, but in less time. The more attractive compounds can then be put on the development fast-track, saving time and money. These two, 1.5 day, back-to-back meetings will provide a forum for discussion of new techniques, technologies, and strategies that hold promise for improving the selection of potent, on-target leads with fewer negative side-effects, thus saving time and money.

Organized by:

Cambridge Healthtech Institute

Deadline for Abstracts:

Registration:

To register visit: www.healthtech.com/2003/adm/reg.asp call 617-630-1300.

E-mail:

chi@healthtech.com

Posted by:

Lisa Cardinale

Host:

wks140.healthtech.com